Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Recommendations for respiratory syncytial virus surveillance at the national level

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genetic association study of childhood aggression across raters, instruments, and age

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term exposure to ambient air pollution and road traffic noise and asthma incidence in adults: The Danish Nurse cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fish Oil Supplementation in Pregnancy and Neurodevelopment in Childhood-A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The trans-ancestral genomic architecture of glycemic traits

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. High-Dose Vitamin D During Pregnancy and Pathway Gene Polymorphisms in Prevention of Offspring Persistent Wheeze

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Prenatal vitamin D3 supplementation has been linked to reduced risk of early-life asthma/recurrent wheeze. This protective effect appears to be influenced by variations in the 17q21 functional single nucleotide polymorphism rs12936231 of the child, which regulates the expression of ORMDL3 (ORM1-like 3) and for which the high-risk CC genotype is associated with early-onset asthma. However, this does not fully explain the differential effects of supplementation. We investigated the influence of maternal rs12936231 genotype variation on the protective effect of prenatal vitamin D3 supplementation against offspring asthma/recurrent wheeze.

METHODS: We determined the rs12936231 genotype of mother-child pairs from two randomised controlled trials: the Vitamin D Antenatal Asthma Reduction Trial (VDAART, n=613) and the Copenhagen Prospective Studies on Asthma in Childhood 2010 (COPSAC2010, n=563), to examine the effect of maternal genotype variation on offspring asthma/recurrent wheeze at age 0-3 years between groups who received high-dose prenatal vitamin D3 supplementation versus placebo.

RESULTS: Offspring of mothers with the low-risk GG or GC genotype who received high-dose vitamin D3 supplementation had a significantly reduced risk of asthma/recurrent wheeze when compared with the placebo group (hazard ratio (HR) 0.54, 95% CI 0.37-0.77; p<0.001 for VDAART and HR 0.56, 95% CI 0.35-0.92; p=0.021 for COPSAC2010), whereas no difference was observed among the offspring of mothers with the high-risk CC genotype (HR 1.05, 95% CI 0.61-1.84; p=0.853 for VDAART and HR 1.11, 95% CI 0.54-2.28; p=0.785 for COPSAC2010).

CONCLUSION: Maternal 17q21 genotype has an important influence on the protective effects of prenatal vitamin D3 supplementation against offspring asthma/recurrent wheeze.

OriginalsprogEngelsk
Artikelnummer2002012
TidsskriftThe European respiratory journal
Vol/bind58
Udgave nummer3
Sider (fra-til)2002012
ISSN0903-1936
DOI
StatusUdgivet - sep. 2021

ID: 64084085